C24847BLUE Car RC CNC Flux C1 & SC Apache 1/8 HPI for Arm Suspension Lower Front Suspension & Steering Parts


  1. Home
  2. C24847BLUE Car RC CNC Flux C1 & SC Apache 1/8 HPI for Arm Suspension Lower Front
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
RC Car C24847BLUE CNC Front Lower Suspension Arm for HPI 1/8 Apache SC & C1 Flux
Condition: New: A brand-new, unused, unopened, undamaged item (including handmade items). See the seller's Fuel Source: Electric
Scale: 1:08 For Vehicle Type: Buggy
MPN:

C24847BLUE

Brand:

Integy

For Vehicle Brand: HPI UPC:

Does not apply

published on tue nov 09 2021

C24847BLUE Car RC CNC Flux C1 & SC Apache 1/8 HPI for Arm Suspension Lower Front Suspension & Steering Parts

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

C24847BLUE Car RC CNC Flux C1 & SC Apache 1/8 HPI for Arm Suspension Lower Front Suspension & Steering Parts

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS